ASP Isotopes Inc. Common Stock
ASPI
NASDAQ·Basic Materials·Chemicals - Specialty·Mkt cap $528.8M
$4.20
▲ +7.69%
P/E
-2.82
Mkt Cap
$528.8M
52-Wk Range
$3.51–$14.49
52-Week Range
$3.51 - $14.49
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 50.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Specialized focus on high-purity isotope production with limited competition
- Diversified isotope portfolio serving multiple high-growth industries
- Early-stage positioning in emerging isotope supply chain market
- Strategic location in Florida with access to research and medical institutions
Bear Case
1 risk
- Very high volatility (beta 3.6). Expect 3x market swings. Position size accordingly.
Growth
Stable outlook
Increasing global demand for medical isotopes in diagnostic imaging and cancer treatment
Value
Trading at 0.0x Commodity Chemicals peers — a discount despite the growth profile.
Momentum
Falling
-38.5% over 3m
Quality
Thin
Emerging growth company (500% revenue growth). Early stage with higher risk.
Dividend
None
No dividend
Smart-money signal
Who's buying ASPI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 12, 2026
AUG 14, 2026
Reported EPS of -$0.28 vs -$0.17 consensus (-64.7% surprise). Revenue of $5.1M vs $4.5M expected (+14.7%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-64.7%
Revenue trend · last 8Q
—
+176%
+31%
+17%
+350%
+1295%
+279%
+328%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$1.1M
$1.2M
$1.1M
$1.2M
$4.9M
$16.7M
$4.2M
$5.1M
Margins · last 8Q
Gross
28.9%
Operating
—
Profit
-655.6%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Canaccord · Apr 14, 2026
vs Industry
How ASPI stacks vs Chemicals - Specialty
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related